Cytoreductive Surgery And HIPEC: An Overview
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is an innovative
procedure used to treat cancers that have originated in or spread to the abdominal cavity, such as
appendiceal cancer, pseudomyxoma peritonei, colon cancer, gastric cancer, ovarian cancer, and
peritoneal mesothelioma. It is a Two part procedure involving surgical removal of cancer followed by
heated chemotherapy instilled in the abdominal cavity for approximately 90 minutes
What Are The Advantages Of Cytoreductive Surgery And HIPEC?
Cancers located in abdominal cavity are challenging to treat. Systemic chemotherapy can be less
effective in treating tumors located on the surface of the abdominal wall and organs. With the use of
Cytoreductive surgery and HIPEC , a chance of cure and improved survival can be offered to patients with
disease limited to the peritoneal cavity and abdomen. In the appearance of recurrences, limited to the
abdomen, HIPEC has become a useful therapeutic strategy.
What Are The Risks Of Cytoreductive Surgery With HIPEC?
Bleeding
Infection
Formation of blood clots
Development of an enterocutaneous fistula or an anastomotic leak
Reduced oral intake resulting in need for TPN
Click here for more details : Cancer Specialist in Pune
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is an innovative
procedure used to treat cancers that have originated in or spread to the abdominal cavity, such as
appendiceal cancer, pseudomyxoma peritonei, colon cancer, gastric cancer, ovarian cancer, and
peritoneal mesothelioma. It is a Two part procedure involving surgical removal of cancer followed by
heated chemotherapy instilled in the abdominal cavity for approximately 90 minutes
What Are The Advantages Of Cytoreductive Surgery And HIPEC?
Cancers located in abdominal cavity are challenging to treat. Systemic chemotherapy can be less
effective in treating tumors located on the surface of the abdominal wall and organs. With the use of
Cytoreductive surgery and HIPEC , a chance of cure and improved survival can be offered to patients with
disease limited to the peritoneal cavity and abdomen. In the appearance of recurrences, limited to the
abdomen, HIPEC has become a useful therapeutic strategy.
What Are The Risks Of Cytoreductive Surgery With HIPEC?
Bleeding
Infection
Formation of blood clots
Development of an enterocutaneous fistula or an anastomotic leak
Reduced oral intake resulting in need for TPN
Click here for more details : Cancer Specialist in Pune
No comments:
Post a Comment